1. Companies

  2. Fibronostics

Fibronostics

Fibronostics

In vitro diagnostics platform for metabolic conditions detection and prognosis, powered by artificial intelligence.
Launch date
Employees
11-50 people
Market cap
-
Enterprise valuation
CAD44—65m (Dealroom.co estimates Aug 2020.)
Orlando Florida (HQ)
https://www.fibronostics.com
https://twitter.com/fibronosticshttps://www.linkedin.com/company/fibronostics/

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD20222023
Revenues1.1m1.1m
    • Edit
DateInvestorsAmountRound
-

N/A

-

$8.0m

Series A
*
N/A

$6.5m

Early VC
Total FundingCAD19.8m

Recent News about Fibronostics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.